0123456789
.
0123456789
0123456789
/10

Score

Capital-infusions

United StatesWithin 1 year(s)
0 Commission

https://capital-infusions.com/home/en/index.html

Website

Time Machine

Rating Index

Brokerage Appraisal

Products

6

Securities Lending Fully Paid、Futures、Investment Advisory Service、Stocks、ETFs、Mutual Funds

support@Capital-infusions.com
https://capital-infusions.com/home/en/index.html
2177 5th Ave #APT 3b New York(NY), 10037

Securities license

Obtain 1 securities license(s)

ASICSuspicious Clone

AustraliaSecurities Trading License

Brokerage Information

More

Company Name

Capital-infusions Pty Ltd (MU)

Company Abbreviation

Capital-infusions

Platform registered country and region

United States

Company address

2177 5th Ave #APT 3b New York(NY), 10037

Check whenever you want

WikiStock APP

Warning: Low score, please stay away!2

Previous Detection: 2024-09-29

  • The Australia Securities & Investment Commission regulation (License No.: 254963) claimed by the brokerage firm is suspected to be a clone firm, please be aware of the risks!
  • It has been verified that this brokerage firm currently has no effective regulation, please be aware of the risk!

Internet Gene

Gene Index

0
020406080100
The gene index is Poor, worse than 0% of brokerage firms.

APP Rating

0
01.02.03.04.05.0
The APP rating is Poor, worse than 0% of peers.

Features of Brokerages

Commission Rate

0%

Minimum Deposit

$200

Margin Trading

YES

Long-Short Equity

YES

Introduction of Brokerage

Capital-infusions was established in United State in 2006 as a provider of online CFD trading services. Our client’s trading journey is very important to us, and as such we are always committed in refining our technology, tailored services and client education. For over a decade, as the industry and clients’ expectations keep evolving, we have positioned ourselves firmly as a trusted and leading United State regulated broker.

Others

Registered region

United States

Years in Business

Within 1 year(s)

Products

Securities Lending Fully Paid、Futures、Investment Advisory Service、Stocks、ETFs、Mutual Funds

Review

0 ratings
Write a comment

No ratings